Barclays lowered the firm’s price target on Visteon (VC) to $130 from $135 and keeps an Equal Weight rating on the shares. The company’s Q3 EBITDA was inline with estimates but its growth was disappointing, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC:
